摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

| 1186091-91-7

中文名称
——
中文别名
——
英文名称
——
英文别名
——
化学式
CAS
1186091-91-7
化学式
C18H19N5O4S
mdl
——
分子量
401.446
InChiKey
STXIDAJXPZOHPE-XWXWGSFUSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.97
  • 重原子数:
    28.0
  • 可旋转键数:
    4.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.33
  • 拓扑面积:
    136.38
  • 氢给体数:
    3.0
  • 氢受体数:
    10.0

反应信息

  • 作为反应物:
    描述:
    甲醇 作用下, 反应 0.5h, 生成 (2R,3R,4S,5S)-2-(6-amino-8-phenylpurin-9-yl)-5-(sulfanylmethyl)oxolane-3,4-diol
    参考文献:
    名称:
    Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues
    摘要:
    Diadenosine disulfide (5) was reported to inhibit NAD kinase from Lysteria monocytogenes and the crystal structure of the enzyme-inhibitor complex has been solved. We have synthesized tiazofurin adenosine disulfide (4) and the disulfide 5, and found that these compounds were moderate inhibitors of human NAD kinase (IC50 = 110 mu M and IC50 = 87 mu M, respectively) and Mycobacterium tuberculosis NAD kinase (IC50 = 80 mu M and IC50 = 45 mu M, respectively). We also found that NAD mimics with a short disulfide (-S-S-) moiety were able to bind in the folded (compact) conformation but not in the common extended conformation, which requires the presence of a longer pyrophosphate (-O-P-O-P-O-) linkage. Since majority of NAD-dependent enzymes bind NAD in the extended conformation, selective inhibition of NAD kinases by disulfide analogues has been observed. Introduction of bromine at the C8 of the adenine ring restricted the adenosine moiety of diadenosine disulfides to the syn conformation making it even more compact. The 8-bromoadenosine adenosine disulfide (14) and its di(8-bromoadenosine) analogue (15) were found to be the most potent inhibitors of human (IC50 = 6 mu M) and mycobacterium NAD kinase (IC50 = 14-19 mu M reported so far. None of the disulfide analogues showed inhibition of lactate-, and inosine monophosphate-dehydrogenase (IMPDH), enzymes that bind NAD in the extended conformation. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.06.013
  • 作为产物:
    描述:
    5'-acetylthio-2',3'-O-isopropylidene 8-phenyladenosine甲酸 作用下, 反应 5.0h, 以72%的产率得到
    参考文献:
    名称:
    Selective inhibition of nicotinamide adenine dinucleotide kinases by dinucleoside disulfide mimics of nicotinamide adenine dinucleotide analogues
    摘要:
    Diadenosine disulfide (5) was reported to inhibit NAD kinase from Lysteria monocytogenes and the crystal structure of the enzyme-inhibitor complex has been solved. We have synthesized tiazofurin adenosine disulfide (4) and the disulfide 5, and found that these compounds were moderate inhibitors of human NAD kinase (IC50 = 110 mu M and IC50 = 87 mu M, respectively) and Mycobacterium tuberculosis NAD kinase (IC50 = 80 mu M and IC50 = 45 mu M, respectively). We also found that NAD mimics with a short disulfide (-S-S-) moiety were able to bind in the folded (compact) conformation but not in the common extended conformation, which requires the presence of a longer pyrophosphate (-O-P-O-P-O-) linkage. Since majority of NAD-dependent enzymes bind NAD in the extended conformation, selective inhibition of NAD kinases by disulfide analogues has been observed. Introduction of bromine at the C8 of the adenine ring restricted the adenosine moiety of diadenosine disulfides to the syn conformation making it even more compact. The 8-bromoadenosine adenosine disulfide (14) and its di(8-bromoadenosine) analogue (15) were found to be the most potent inhibitors of human (IC50 = 6 mu M) and mycobacterium NAD kinase (IC50 = 14-19 mu M reported so far. None of the disulfide analogues showed inhibition of lactate-, and inosine monophosphate-dehydrogenase (IMPDH), enzymes that bind NAD in the extended conformation. (C) 2009 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmc.2009.06.013
点击查看最新优质反应信息

同类化合物

阿糖胞苷杂质6 西奈芬净 腺苷硒基蛋氨酸 脱氧腺嘌呤核苷 甲硫腺苷 环西奈芬净 异丙基2-((2R,3S,4R,5R)-5-(6-氨基-9H-嘌呤-9-基)-3,4-二羟基四氢呋喃-2-基)乙酸酯 尿嘧啶多氧菌素 C 多氧菌素 去氧氟尿苷 卡培他滨杂质N 卡培他滨杂质 卡培他滨中间体1 卡培他滨USP杂质 卡培他滨USP杂质 卡培他滨USP杂质 卡培他滨-d11 卡培他滨 化合物55 加洛他滨 [2-(癸酰氨基)-3-羟基-3-苯基丙基]N-[2-[[(2R,3S,4R,5R)-5-(2,4-二氧代嘧啶-1-基)-3,4-二羟基四氢呋喃-2-基]甲基氨基]-2-氧代乙基]氨基甲酸酯 [(3R,4R,5R)-2-(6-氨基-8-叠氮基嘌呤-9-基)-5-甲基-4-(2,4,6-三硝基苯氧基)四氢呋喃-3-基]氧基二氢磷酸酯 S-腺苷蛋氨酸对甲苯磺酸硫酸盐 S-腺苷蛋氨酸丁二磺酸盐 S-腺苷蛋氨酸 S-腺苷甲硫氨酸对甲苯磺酸盐 S-腺苷基-L-蛋氨碘盐 S-腺苷乙硫氨酸 S-腺苷-L-蛋氨酸 S-腺苷-L-半胱氨酸 S-腺苷-3-硫代丙胺 S-腺苷-3-甲硫基丙胺 S-甲基-5'-甲硫基腺苷 S-次黄苷基高半胱氨酸 S-N(6)-甲基腺苷高半胱氨酸 S-(5’-腺苷基)-L-氯化蛋氨酸 S-(5'-腺苷)-L-高半胱氨酸 N-双环[2.2.1]-2-庚基-5-氯-5-脱氧腺苷酸 N-[6-[2-[[(2S,3S,4R,5R)-3,4-二羟基-5-[6-[(4-硝基苯基)甲基氨基]嘌呤-9-基]四氢呋喃-2-基]甲硫基]乙基氨基]-6-氧代己基]-3',6'-二羟基-3-氧代螺[2-苯并呋喃-1,9'-氧杂蒽]-5-甲酰胺 N(4)-腺苷-N(4)-甲基-2,4-二氨基丁酸 9-{5-[(3-氨基-3-羧基丙基)(甲基)-lambda4-硫基]-5-脱氧呋喃戊糖基}-9H-嘌呤-6-胺 9-[(2R,3R,4S,5R)-3,4-二羟基-5-甲基四氢呋喃-2-基]-3H-嘌呤-2,6-二酮 9-(5-脱氧-beta-D-核-呋喃己糖基)-9H-嘌呤-6-胺 9-(5',6'-二脱氧-beta-己-5'-炔呋喃核糖基)腺嘌呤 8-氨基[1”-(N”-丹磺酰)-4”-氨基丁基]-5’-(1-氮丙啶基)-5’-脱氧腺苷 8-叠氮基-S-腺苷蛋氨酸 6-氯-9-(5-脱氧-D-呋喃核糖基)-9H-嘌呤 6-氨基-9-(5-脱氧-alpha-D-呋喃木糖基)-9H-嘌呤 5′-氨基-5′-脱氧腺苷对甲苯磺酸盐 5’-脱氧-5-氟胞嘧啶核苷